Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

425 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease.
Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Blacher J, et al. Hypertension. 2001 Oct;38(4):938-42. doi: 10.1161/hy1001.096358. Hypertension. 2001. PMID: 11641313
[Hyperhomocysteinemia in coronary artery diseases. Apropos of a study on 102 patients].
Blacher J, Montalescot G, Ankri A, Chadefaux-Vekemans B, Benzidia R, Grosgogeat Y, Kamoun P, Thomas D. Blacher J, et al. Arch Mal Coeur Vaiss. 1996 Oct;89(10):1241-6. Arch Mal Coeur Vaiss. 1996. PMID: 8952820 French.
[First intention treatment of arterial hypertension using a combination of two drugs].
Girerd X, Blacher J, Mourad JJ, Safar M. Girerd X, et al. Among authors: blacher j. Presse Med. 1996 Dec 14;25(39):1941-4. Presse Med. 1996. PMID: 9033616 Review. French.
Plasma homocysteine and the extent of atherosclerosis in patients with coronary artery disease.
Montalescot G, Ankri A, Chadefaux-Vekemans B, Blacher J, Philippe F, Drobinski G, Benzidia R, Kamoun P, Thomas D. Montalescot G, et al. Among authors: blacher j. Int J Cardiol. 1997 Aug 8;60(3):295-300. doi: 10.1016/s0167-5273(97)00099-5. Int J Cardiol. 1997. PMID: 9261641
Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension.
Blacher J, Amah G, Girerd X, Kheder A, Ben Mais H, London GM, Safar ME. Blacher J, et al. Am J Hypertens. 1997 Dec;10(12 Pt 1):1326-34. doi: 10.1016/s0895-7061(97)00301-4. Am J Hypertens. 1997. PMID: 9443767
Endothelin and cardiovascular remodelling in end-stage renal disease.
Demuth K, Blacher J, Guerin AP, Benoit MO, Moatti N, Safar ME, London GM. Demuth K, et al. Among authors: blacher j. Nephrol Dial Transplant. 1998 Feb;13(2):375-83. doi: 10.1093/oxfordjournals.ndt.a027833. Nephrol Dial Transplant. 1998. PMID: 9509449
Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease.
Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM. Blacher J, et al. Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):535-41. doi: 10.1161/01.atv.18.4.535. Arterioscler Thromb Vasc Biol. 1998. PMID: 9555858
Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease.
Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Blacher J, et al. Hypertension. 1998 Sep;32(3):570-4. doi: 10.1161/01.hyp.32.3.570. Hypertension. 1998. PMID: 9740628
[Arterial hypertension, non-drug treatment and cardiovascular risk].
Blacher J, Tartiere JM, Amah G, Campa P, Raison J, Safar M. Blacher J, et al. Ann Cardiol Angeiol (Paris). 1998 Feb;47(2):81-5. Ann Cardiol Angeiol (Paris). 1998. PMID: 9772933 French.
Increased arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after acute administration of the ACE inhibitor moexipril.
Blacher J, Raison J, Amah G, Schiemann AL, Stimpel M, Safar ME. Blacher J, et al. Cardiovasc Drugs Ther. 1998 Sep;12(4):409-14. doi: 10.1023/a:1007733103730. Cardiovasc Drugs Ther. 1998. PMID: 9825188 Clinical Trial.
425 results
Jump to page